The experiences of balloon-expandable stent in symptomatic stenosis of middle cerebral artery

Tang, Lingtao; Hu, Pengfei; Liu, Yalin; Zhang, Kunxi; Wang, Yun; Dong, Qin; Xia, Zhongshuang; Qi, Shanshan; Zhang, Suxia; Zhang, Hongmei; Li, Weiyue; Zhang, Bogang; Yang, Xingdan; Li, Yingyi

doi:10.1186/s40064-016-3078-4

Cited by 4 publications

(4 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, few studies have investigated the long-term outcomes after balloon-mounted stenting for symptomatic ICAS with experienced interventionalists and proper patient selection. 17 18 The 1-year rates of any stroke, ischemic stroke, hemorrhagic stroke, and death were 8.5%, 8.5%, 0%, and 1.6% in the WOVEN study, and comparable values were found using balloon-mounted stents in the present study. 13 …”

Section: Discussionsupporting

confidence: 84%

“…11 The Apollo stent (MicroPort Neuro Tech, Shanghai, China) is a balloon-mounted stent with a metallic surface area of about 14.0%, approved by the Chinese Food and Drug Administration for use in patients with symptomatic ICAS. Although several case series have supported its safety and efficacy since 2003, [14][15][16][17][18] a prospective multicenter registry study has not been carried out.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Balloon-mounted stenting for ICAS in a multicenter registry study in China: a comparison with the WEAVE/WOVEN trial

Kang

Zhang

Shuai

et al. 2020

J NeuroIntervent Surg

View full text Add to dashboard Cite

BackgroundThe outcome of deploying balloon-mounted stents for symptomatic intracranial atherosclerotic stenosis (ICAS) has not been fully investigated. In this study we evaluate the safety and long-term outcome of using balloon-mounted stents to treat symptomatic ICAS in comparison with the WEAVE/WOVEN study.MethodsIn a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China, 159 patients treated with an intracranial balloon-mounted stent approved by the China Food and Drug Administration were evaluated. The morphological features of the lesions were categorized by Mori classification. The endpoints, including periprocedural and long-term clinical and radiological outcomes, were the same as those in the WEAVE/WOVEN study.ResultsIn the present study the mean percent stenosis before and after stenting was 84.0% and 6.1%, respectively. The proportions of Mori A, Mori B, and Mori C lesions were 33.3%, 52.2%, and 14.5%, respectively. The 72-hour rates of stroke and mortality after the procedure were 0%. The 1-year rates of any stroke, ischemic stroke, hemorrhagic stroke, and death were 6.3% (10/159), 5.7% (9/159), 0.6% (1/159), and 0.6% (1/159), respectively. The 1-year rate of in-stent restenosis (ISR) was 23.4% (15/64). The rate of ISR in Mori C lesions (53.8%, 7/13) was significantly higher than that in Mori A (15.8%, 3/19) or Mori B lesions (15.6%, 5/32) (p=0.024).ConclusionsThe short-term and long-term outcomes of using a balloon-mounted stent for symptomatic ICAS with focal and non-angular lesions (Mori A and B type) and smooth arterial access were comparable to the results of the WEAVE/WOVEN trial.

show abstract

Section: Discussionsupporting

confidence: 84%

Section: Introductionmentioning

confidence: 99%

Balloon-mounted stenting for ICAS in a multicenter registry study in China: a comparison with the WEAVE/WOVEN trial

Kang

Zhang

Shuai

et al. 2020

J NeuroIntervent Surg

View full text Add to dashboard Cite

show abstract

“…There have been several reports of its intracranial use for middle cerebral artery (MCA) stenosis or ICA stenosis, including drug-eluting stents (DES). [17][18][19] However, if these stents can be successfully used for MCA and intracranial ICA, it is clear that they can also be used for more proximal extracranial ICAs. As such, BECo stents should be considered as an option for CAS procedures.…”

Section: Discussionmentioning

confidence: 99%

Carotid Artery Stenting Using Balloon-Expandable Coronary Stent: Intentional Use for Staged Angioplasty

Ezura

Kimura

Sakata

et al. 2021

JNET

View full text Add to dashboard Cite

We report carotid artery stenting (CAS) using balloon-expandable coronary (BECo) stent. The materials in this study consist of 15 cases of high-grade stenosis in internal carotid artery (ICA) in which self-expanding carotid (SECa) stent was not utilized. There were two groups why BECo stent was used instead of SECa stent: alternative group and intentional group. The alternative group was subdivided into two groups: access difficulty of guiding catheter and access difficulty of SECa stent. Case Presentations:The alternative group included 11 cases (access difficulty of guiding catheter in 10 and access difficulty of SECa stent in 1), and the intentional group included 4 cases. There were four cases using transbrachial approach. All the intentional group cases were the first stage of staged angioplasty (SAP). The second stage of SAP was PTA in two and SECa stent over the BECo stent in two. There was no complication related to CAS. Conclusion:CAS using BECo stent is one of the choices for the first stage of SAP, if stent placement instead of PTA is required at the first stage. It is also the useful alternative for the patient having difficulty of SECa stent.Keywords▶ balloon-expandable stent, coronary stent, self-expanding stent, carotid stent, staged angioplasty This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives International License.

show abstract

“…Although in several studies balloon angioplasty was done prior to stenting in the SES group, BMS is more effective in reducing the stenosis of arteries. [27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] Details of meta-analysis have been demonstrated in appendix 1.…”

Section: Changes In the Degree Of Stenosismentioning

confidence: 99%

Balloon-mounting stent for intracranial arterial stenosis: A comprehensive and comparative systematic review and meta-analysis

et al. 2022

View full text Add to dashboard Cite

Introduction As one of the major causes of acute ischemic stroke, intracranial arterial stenosis necessitates an intervention that ranges from medical treatment to balloon angioplasty and stenting. Self-expandable stents (SES) and balloon-mounted stents (BMS) are two types of stents and their comparative efficacy and safety for intracranial stenosis are not well established. Methods Studies that investigate balloon-mounted stenting for intracranial stenosis were extracted from PubMed, Scopus, and Cochrane library. We sought to gather data on the success rate, change in mean arterial stenosis, and complications such as minor and major stroke and death (MMD), symptomatic intracranial hemorrhage, myocardial infarction, all-cause mortality, and in-stent re-stenosis. Results 3049 patients from 35 studies were included in this study. 20 studies investigated BMS alone and others compared BMS with SES. BMS was significantly more effective in reducing the degree of stenosis compared to SES (Difference in mean −5.953, CI 95% −7.727 to −4.179), had less complications compared to SES such as MMD (8.5% vs. 11.2%) and less in-stent re-stenosis (18.6% vs. 19.6%), but patients with SES experienced a lower rate of all-cause mortality(1.7% vs. 4.1%). Conclusion Intracranial stenting with BMS is more effective in reducing the degree of stenosis and has lower rates of complications when compared to SES.

show abstract

The experiences of balloon-expandable stent in symptomatic stenosis of middle cerebral artery

Cited by 4 publications

References 32 publications

Balloon-mounted stenting for ICAS in a multicenter registry study in China: a comparison with the WEAVE/WOVEN trial

Balloon-mounted stenting for ICAS in a multicenter registry study in China: a comparison with the WEAVE/WOVEN trial

Carotid Artery Stenting Using Balloon-Expandable Coronary Stent: Intentional Use for Staged Angioplasty

Balloon-mounting stent for intracranial arterial stenosis: A comprehensive and comparative systematic review and meta-analysis

Contact Info

Product

Resources

About